Steven Chang

Steven Chang, PhD, is an accomplished professional in the biopharmaceutical and medical research sectors, currently serving as the Associate Director of Pipeline Forecasting & Analytics at Jazz Pharmaceuticals since January 2024. Previous experience includes an Engagement Manager role at Health Advances, leading teams on strategic consulting projects within biopharma and diagnostics, and various positions at Simon-Kucher & Partners focused on pricing and market access strategies. Steven's early research background includes significant contributions at the Massachusetts Institute of Technology, where groundbreaking work on DNA damage and mutagenesis was published. Steven holds a PhD in Biological Engineering from MIT and a Bachelor of Science in Chemical Engineering from the University of Illinois Urbana-Champaign.